| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.562 | 0.02 | 0.562 | Streptokinase A inhibitor | |||
| 0.529 | 0.019 | 0.529 | GABA C receptor rho-3 antagonist | |||
| 0.489 | 0.036 | 0.594 | 5 Hydroxytryptamine release inhibitor | 0.594 0.012 CID_154699760 | CID_154699760 | |
| 0.53 | 0.078 | 0.53 | DNA polymerase beta inhibitor | |||
| 0.487 | 0.043 | 0.487 | 15-Lipoxygenase inhibitor | |||
| 0.475 | 0.034 | 0.475 | Thioredoxin glutathione reductase inhibitor | |||
| 0.426 | 0.003 | 0.426 | Ferrochelatase inhibitor | 0.09 0.083 CID_154699760 | ||
| 0.492 | 0.085 | 0.492 | DNA directed DNA polymerase inhibitor | |||
| 0.46 | 0.055 | 0.46 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.438 | 0.084 | 0.438 | MAP kinase 1 inhibitor | |||
| 0.352 | 0.007 | 0.352 | NADPH oxidase inhibitor | 0.118 0.085 CID_154699760 | ||
| 0.345 | 0.01 | 0.345 | Glycogen synthase kinase-3 beta inhibitor | |||
| 0.338 | 0.008 | 0.338 | Alkaline phosphatase inhibitor | 0.197 0.034 CID_154699760 | ||
| 0.338 | 0.021 | 0.338 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | |||
| 0.337 | 0.023 | 0.337 | CDC-like kinase 4 inhibitor | |||
| 0.327 | 0.013 | 0.327 | Glycogen synthase kinase-3 inhibitor | |||
| 0.417 | 0.107 | 0.613 | Alpha-glucosidase inhibitor | 0.613 0.051 CID_154699760 | CID_154699760 | |
| 0.393 | 0.086 | 0.393 | Calcium channel L-type activator | |||
| 0.306 | 0.012 | 0.306 | Aurora-A kinase inhibitor | |||
| 0.376 | 0.088 | 0.637 | Histamine release inhibitor | 0.637 0.007 CID_154699760 | CID_154699760 | |
| 0.414 | 0.131 | 0.806 | Antiinflammatory | 0.806 0.014 CID_154699760 | CID_154699760 | |
| 0.303 | 0.038 | 0.303 | Clk dual-specificity kinase inhibitor | |||
| 0.297 | 0.038 | 0.297 | Peroxidase inhibitor | |||
| 0.258 | 0.01 | 0.281 | Mannose-6-phosphate isomerase inhibitor | 0.281 0.007 CID_154699760 | CID_154699760 | |
| 0.315 | 0.078 | 0.315 | Calcium channel activator | |||
| 0.319 | 0.094 | 0.319 | Prostaglandin dehydrogenase inhibitor | |||
| 0.238 | 0.04 | 0.238 | Mcl-1 antagonist | |||
| 0.255 | 0.063 | 0.255 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.262 | 0.074 | 0.262 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.271 | 0.097 | 0.271 | 12-Lipoxygenase inhibitor | |||
| 0.201 | 0.028 | 0.201 | GABA C receptor rho-2 antagonist | |||
| 0.238 | 0.068 | 0.238 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.204 | 0.034 | 0.293 | ATPase inhibitor | 0.293 0.007 CID_154699760 | CID_154699760 | |
| 0.26 | 0.094 | 0.26 | Lipoxygenase inhibitor | |||
| 0.182 | 0.021 | 0.182 | 5 Hydroxytryptamine 3A agonist | |||
| 0.16 | 0.001 | 0.16 | CD80 antagonist | |||
| 0.192 | 0.036 | 0.192 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.243 | 0.087 | 0.243 | Gastrin inhibitor | |||
| 0.188 | 0.04 | 0.188 | Cyclooxygenase 1 inhibitor | 0.126 0.075 CID_154699760 | ||
| 0.246 | 0.1 | 0.246 | Insulysin inhibitor | |||
| 0.236 | 0.096 | 0.236 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.193 | 0.054 | 0.193 | Heat shock protein 90 alpha antagonist | |||
| 0.178 | 0.041 | 0.43 | Alpha-N-acetylglucosaminidase inhibitor | 0.43 0.008 CID_154699760 | CID_154699760 | |
| 0.156 | 0.021 | 0.156 | Creatine kinase inhibitor | |||
| 0.197 | 0.062 | 0.197 | Dual specificity phosphatase 3 inhibitor | |||
| 0.19 | 0.057 | 0.19 | Succinate dehydrogenase inhibitor | |||
| 0.179 | 0.051 | 0.179 | Cyclooxygenase inhibitor | 0.175 0.054 CID_154699760 | ||
| 0.141 | 0.013 | 0.141 | Myeloperoxidase inhibitor | |||
| 0.163 | 0.038 | 0.163 | Cathepsin H inhibitor | |||
| 0.151 | 0.026 | 0.239 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.239 0.011 CID_154699760 | CID_154699760 | |
| 0.2 | 0.075 | 0.2 | Death-associated protein kinase 3 inhibitor | |||
| 0.174 | 0.05 | 0.174 | RET inhibitor | |||
| 0.208 | 0.088 | 0.295 | Cyclic AMP phosphodiesterase inhibitor | 0.295 0.044 CID_154699760 | CID_154699760 | |
| 0.142 | 0.022 | 0.142 | Porphobilinogen synthase inhibitor | |||
| 0.165 | 0.048 | 0.165 | c-Src kinase inhibitor | |||
| 0.265 | 0.15 | 0.265 | Beta lactamase inhibitor | |||
| 0.271 | 0.158 | 0.602 | Antibacterial | 0.602 0.019 CID_154699760 | CID_154699760 | |
| 0.197 | 0.084 | 0.197 | MAP kinase kinase 2 inhibitor | |||
| 0.135 | 0.026 | 0.135 | Factor V inhibitor | |||
| 0.207 | 0.101 | 0.207 | Aldehyde oxidase inhibitor | |||
| 0.162 | 0.057 | 0.162 | CF transmembrane conductance regulator agonist | |||
| 0.165 | 0.065 | 0.165 | Cytidine deaminase inhibitor | |||
| 0.136 | 0.038 | 0.136 | GABA C receptor antagonist | |||
| 0.12 | 0.023 | 0.12 | Bromodomain-containing protein 2 inhibitor | |||
| 0.186 | 0.09 | 0.186 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.163 | 0.073 | 0.163 | Arachidonic acid antagonist | 0.126 0.119 CID_154699760 | ||
| 0.183 | 0.096 | 0.183 | Histone acetyltransferase inhibitor | |||
| 0.144 | 0.059 | 0.156 | Ca2+-transporting ATPase inhibitor | 0.156 0.03 CID_154699760 | CID_154699760 | |
| 0.123 | 0.041 | 0.123 | Adenylate kinase inhibitor | 0.105 0.06 CID_154699760 | ||
| 0.148 | 0.069 | 0.148 | Activin receptor-like kinase 2 inhibitor | |||
| 0.132 | 0.054 | 0.132 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.119 | 0.041 | 0.119 | GABA C receptor rho-1 antagonist | |||
| 0.123 | 0.046 | 0.19 | Xanthine oxidase inhibitor | 0.19 0.022 CID_154699760 | CID_154699760 | |
| 0.087 | 0.012 | 0.087 | Glutamate (mGluR group III) agonist | |||
| 0.187 | 0.112 | 0.198 | Nitric-oxide synthase stimulant | 0.198 0.093 CID_154699760 | CID_154699760 | |
| 0.122 | 0.048 | 0.122 | GABA C receptor agonist | |||
| 0.113 | 0.049 | 0.338 | UDP-glucose 4-epimerase inhibitor | 0.338 0.008 CID_154699760 | CID_154699760 | |
| 0.115 | 0.051 | 0.115 | CDC-like kinase 3 inhibitor | |||
| 0.144 | 0.081 | 0.144 | Heat shock protein 90 antagonist | |||
| 0.167 | 0.105 | 0.167 | Focal adhesion kinase 2 inhibitor | |||
| 0.155 | 0.093 | 0.155 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.108 | 0.048 | 0.108 | Electrolyte absorption antagonist | |||
| 0.152 | 0.092 | 0.152 | Dual specificity phosphatase inhibitor | |||
| 0.154 | 0.096 | 0.154 | Tumour necrosis factor antagonist | |||
| 0.128 | 0.07 | 0.128 | M17 leucyl aminopeptidase inhibitor | |||
| 0.248 | 0.193 | 0.248 | MAP kinase kinase 6 inhibitor | |||
| 0.071 | 0.016 | 0.071 | Dihydroorotate oxidase inhibitor | |||
| 0.205 | 0.152 | 0.205 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.194 | 0.142 | 0.194 | MAP kinase kinase 3 inhibitor | |||
| 0.15 | 0.098 | 0.15 | LIM domain kinase 1 inhibitor | |||
| 0.16 | 0.109 | 0.16 | I kappa B kinase epsilon inhibitor | |||
| 0.127 | 0.077 | 0.564 | Amylase inhibitor | 0.564 0.004 CID_154699760 | CID_154699760 | |
| 0.161 | 0.116 | 0.161 | Anticonvulsant | |||
| 0.138 | 0.093 | 0.138 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.054 | 0.01 | 0.054 | Glutamate (mGluR4) agonist | |||
| 0.055 | 0.012 | 0.055 | Angiotensin AT1 receptor antagonist | |||
| 0.095 | 0.053 | 0.222 | Triose-phosphate isomerase inhibitor | 0.222 0.009 CID_154699760 | CID_154699760 | |
| 0.072 | 0.03 | 0.072 | Xanthine dehydrogenase inhibitor | |||
| 0.071 | 0.029 | 0.071 | Transcription factor RelA inhibitor | |||
| 0.093 | 0.052 | 0.211 | NADH dehydrogenase inhibitor | 0.211 0.01 CID_154699760 | CID_154699760 | |
| 0.2 | 0.162 | 0.2 | Thyroid hormone antagonist | |||
| 0.161 | 0.124 | 0.161 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.085 | 0.048 | 0.085 | CC chemokine 5 receptor agonist | |||
| 0.147 | 0.112 | 0.147 | Phospholipase C inhibitor | |||
| 0.077 | 0.043 | 0.077 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.147 | 0.114 | 0.147 | Death-associated protein kinase 2 inhibitor | |||
| 0.067 | 0.034 | 0.067 | Biliverdin reductase inhibitor | |||
| 0.073 | 0.041 | 0.073 | CDC7 inhibitor | |||
| 0.07 | 0.039 | 0.07 | Cyclin A2 inhibitor | |||
| 0.115 | 0.085 | 0.155 | Cyclooxygenase 2 inhibitor | 0.155 0.05 CID_154699760 | CID_154699760 | |
| 0.103 | 0.073 | 0.116 | Cystathionine beta-synthase inhibitor | 0.116 0.061 CID_154699760 | CID_154699760 | |
| 0.068 | 0.039 | 0.068 | Cyclin A inhibitor | |||
| 0.091 | 0.063 | 0.091 | Protein kinase C zeta inhibitor | |||
| 0.093 | 0.064 | 0.093 | Potassium channel (Voltage-sensitive) activator | |||
| 0.071 | 0.042 | 0.071 | Exportin-1 inhibitor | |||
| 0.045 | 0.017 | 0.045 | Nicotinic acid receptor agonist | |||
| 0.051 | 0.025 | 0.051 | Adenylate cyclase 1 inhibitor | |||
| 0.19 | 0.164 | 0.19 | Thyroid hormone beta antagonist | |||
| 0.04 | 0.014 | 0.04 | Angiotensin II receptor antagonist | |||
| 0.156 | 0.131 | 0.156 | Aryl hydrocarbon receptor agonist | |||
| 0.06 | 0.036 | 0.06 | Alcohol oxidase inhibitor | |||
| 0.091 | 0.069 | 0.091 | Phosphodiesterase 7B inhibitor | |||
| 0.06 | 0.04 | 0.06 | Phosphodiesterase 1A inhibitor | |||
| 0.054 | 0.035 | 0.054 | GABA A receptor antagonist | |||
| 0.057 | 0.039 | 0.082 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.082 0.019 CID_154699760 | CID_154699760 | |
| 0.092 | 0.074 | 0.092 | Anabolic | |||
| 0.059 | 0.041 | 0.059 | Cyclin A1 inhibitor | |||
| 0.069 | 0.053 | 0.069 | Benzodiazepine agonist | |||
| 0.118 | 0.102 | 0.118 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.054 | 0.038 | 0.054 | GABA receptor antagonist | |||
| 0.051 | 0.036 | 0.051 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.029 | 0.015 | 0.029 | CXC chemokine 2 receptor antagonist | |||
| 0.066 | 0.051 | 0.066 | Glutamate (mGluR7) antagonist | |||
| 0.041 | 0.029 | 0.041 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.027 | 0.016 | 0.027 | Thymidine phosphorylase inhibitor | |||
| 0.028 | 0.016 | 0.028 | Nicotinic acid receptor 2 antagonist | |||
| 0.02 | 0.009 | 0.02 | Nicotinic acid receptor 1 antagonist | |||
| 0.057 | 0.046 | 0.057 | Phosphodiesterase 1B inhibitor | |||
| 0.1 | 0.09 | 0.1 | TRKA antagonist | |||
| 0.168 | 0.158 | 0.168 | Superoxide dismutase inhibitor | |||
| 0.085 | 0.076 | 0.085 | MAO A inhibitor | |||
| 0.059 | 0.05 | 0.059 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.079 | 0.071 | 0.079 | D-Ala-D-Ala ligase inhibitor | |||
| 0.118 | 0.11 | 0.118 | Aurora-C kinase inhibitor | |||
| 0.037 | 0.029 | 0.037 | Alpha 1d adrenoreceptor agonist | |||
| 0.024 | 0.017 | 0.024 | NMDA receptor glycine site antagonist | |||
| 0.067 | 0.06 | 0.069 | Glycine receptor agonist | 0.069 0.056 CID_154699760 | CID_154699760 | |
| 0.08 | 0.074 | 0.08 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.094 | 0.088 | 0.094 | Protein kinase C gamma inhibitor | |||
| 0.038 | 0.032 | 0.038 | Glutamate (mGluR1a) antagonist | |||
| 0.058 | 0.053 | 0.058 | Phosphodiesterase 1C inhibitor | |||
| 0.054 | 0.049 | 0.054 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.116 | 0.112 | 0.116 | Src kinase inhibitor | |||
| 0.11 | 0.105 | 0.346 | Protein kinase stimulant | 0.346 0.012 CID_154699760 | CID_154699760 | |
| 0.065 | 0.062 | 0.065 | Glutamate decarboxylase inhibitor | |||
| 0.064 | 0.06 | 0.064 | MDM2 inhibitor | |||
| 0.073 | 0.07 | 0.073 | MAP kinase kinase 7 inhibitor | |||
| 0.018 | 0.017 | 0.035 | Purinergic P2T antagonist | 0.035 0.011 CID_154699760 | CID_154699760 | |
| 0.038 | 0.037 | 0.038 | Histamine H2 receptor agonist | |||
| 0.035 | 0.034 | 0.035 | Vascular adhesion protein 1 inhibitor | |||
| 0.053 | 0.055 | 0.056 | Purinergic P2X1 antagonist | 0.056 0.05 CID_154699760 | CID_154699760 | |
| 0.043 | 0.046 | 0.047 | Topoisomerase II beta inhibitor | 0.047 0.038 CID_154699760 | CID_154699760 | |
| 0.128 | 0.134 | 0.142 | Heat shock protein 70 antagonist | 0.142 0.068 CID_154699760 | CID_154699760 | |
| 0.041 | 0.049 | 0.078 | Glucose-6-phosphate isomerase inhibitor | 0.078 0.009 CID_154699760 | CID_154699760 | |
| 0.159 | 0.177 | 0.182 | RNA-directed DNA polymerase inhibitor | 0.182 0.129 CID_154699760 | CID_154699760 | |
| 0.036 | 0.055 | 0.066 | Carbonic anhydrase IX inhibitor | 0.066 0.034 CID_154699760 | CID_154699760 | |
| 0.048 | 0.071 | 0.177 | Phosphofructokinase-1 inhibitor | 0.177 0.014 CID_154699760 | CID_154699760 | |
| 0.064 | 0.088 | 0.106 | Glycine receptor antagonist | 0.106 0.027 CID_154699760 | CID_154699760 | |
| 0.128 | 0.154 | 0.41 | Non-steroidal antiinflammatory agent | 0.41 0.012 CID_154699760 | CID_154699760 | |
| 0.01 | 0.046 | 0.021 | Telomerase stimulant | 0.021 0.007 CID_154699760 | CID_154699760 | |
| 0.108 | 0.145 | 0.392 | Hemostatic | 0.392 0.008 CID_154699760 | CID_154699760 | |
| 0.162 | 0.2 | 0.226 | Hypoxia-inducible factor 1 alpha inhibitor | 0.226 0.123 CID_154699760 | CID_154699760 | |
| 0.152 | 0.199 | 0.323 | DNA synthesis inhibitor | 0.323 0.037 CID_154699760 | CID_154699760 | |
| 0.102 | 0.151 | 0.232 | Hexokinase inhibitor | 0.232 0.021 CID_154699760 | CID_154699760 | |
| 0.23 | 0.279 | 0.34 | Caspase 9 stimulant | 0.34 0.154 CID_154699760 | CID_154699760 | |
| 0.076 | 0.125 | 0.173 | Beta glucuronidase inhibitor | 0.173 0.017 CID_154699760 | CID_154699760 | |
| 0.096 | 0.147 | 0.186 | DNA repair enzyme inhibitor | 0.186 0.012 CID_154699760 | CID_154699760 | |
| 0.036 | 0.088 | 0.063 | Cytokine production stimulant | 0.063 0.011 CID_154699760 | CID_154699760 | |
| 0.015 | 0.071 | 0.029 | Vanilloid 2 agonist | 0.029 0.011 CID_154699760 | CID_154699760 | |
| 0.015 | 0.072 | 0.087 | Sodium/glucose cotransporter inhibitor | 0.087 0.003 CID_154699760 | CID_154699760 | |
| 0.081 | 0.141 | 0.238 | Cyclooxygenase 3 inhibitor | 0.238 0.01 CID_154699760 | CID_154699760 | |
| 0.018 | 0.081 | 0.078 | Carbonic anhydrase XII inhibitor | 0.078 0.026 CID_154699760 | CID_154699760 | |
| 0.022 | 0.086 | 0.048 | Guanylate cyclase inhibitor | 0.048 0.023 CID_154699760 | CID_154699760 | |
| 0.073 | 0.137 | 0.117 | Phosphodiesterase 6D inhibitor | 0.117 0.028 CID_154699760 | CID_154699760 | |
| 0.107 | 0.172 | 0.261 | Interferon gamma antagonist | 0.261 0.026 CID_154699760 | CID_154699760 | |
| 0.066 | 0.131 | 0.097 | Carbonic anhydrase III inhibitor | 0.097 0.066 CID_154699760 | CID_154699760 | |
| 0.114 | 0.181 | 0.147 | Lipocortins synthesis antagonist | 0.147 0.109 CID_154699760 | CID_154699760 | |
| 0.04 | 0.11 | 0.088 | Carbonic anhydrase XIII inhibitor | 0.088 0.045 CID_154699760 | CID_154699760 | |
| 0.018 | 0.088 | 0.088 | Purinergic P2Y antagonist | 0.088 0.011 CID_154699760 | CID_154699760 | |
| 0.01 | 0.087 | 0.024 | Antibiotic Anthracycline-like | 0.024 0.005 CID_154699760 | CID_154699760 | |
| 0.099 | 0.182 | 0.238 | DNA methyltransferase I inhibitor | 0.238 0.052 CID_154699760 | CID_154699760 | |
| 0.037 | 0.127 | 0.098 | Na+ K+ transporting ATPase inhibitor | 0.098 0.033 CID_154699760 | CID_154699760 | |
| 0.073 | 0.165 | 0.112 | Photosensitizer | 0.112 0.069 CID_154699760 | CID_154699760 | |
| 0.052 | 0.145 | 0.105 | Mediator release inhibitor | 0.105 0.064 CID_154699760 | CID_154699760 | |
| 0.028 | 0.123 | 0.074 | Alpha-mannosidase inhibitor | 0.074 0.014 CID_154699760 | CID_154699760 | |
| 0.095 | 0.19 | 0.149 | Anesthetic general | 0.149 0.115 CID_154699760 | CID_154699760 | |
| 0.018 | 0.13 | 0.065 | Mannosidase inhibitor | 0.065 0.014 CID_154699760 | CID_154699760 | |
| 0.101 | 0.213 | 0.286 | Interleukin agonist | 0.286 0.055 CID_154699760 | CID_154699760 | |
| 0.139 | 0.258 | 0.313 | Vasodilator, coronary | 0.313 0.078 CID_154699760 | CID_154699760 | |
| 0.008 | 0.135 | 0.075 | Sodium/glucose cotransporter 2 inhibitor | 0.075 0.004 CID_154699760 | CID_154699760 | |
| 0.005 | 0.14 | 0.049 | Purinergic P2Y1 antagonist | 0.049 0.004 CID_154699760 | CID_154699760 | |
| 0.075 | 0.215 | 0.201 | Cell wall synthesis inhibitor | 0.201 0.029 CID_154699760 | CID_154699760 | |
| 0.087 | 0.227 | 0.232 | DNA methylase inhibitor | 0.232 0.059 CID_154699760 | CID_154699760 | |
| 0.053 | 0.197 | 0.113 | Interleukin 5 antagonist | 0.113 0.029 CID_154699760 | CID_154699760 | |
| 0.053 | 0.2 | 0.112 | Adenylate cyclase inhibitor | 0.112 0.074 CID_154699760 | CID_154699760 | |
| 0.086 | 0.234 | 0.162 | Melanin inhibitor | 0.162 0.067 CID_154699760 | CID_154699760 | |
| 0.122 | 0.277 | 0.43 | Cholesterol antagonist | 0.43 0.044 CID_154699760 | CID_154699760 | |
| 0.09 | 0.249 | 0.527 | Free radical scavenger | 0.527 0.014 CID_154699760 | CID_154699760 | |
| 0.026 | 0.185 | 0.089 | Heparanase inhibitor | 0.089 0.005 CID_154699760 | CID_154699760 | |
| 0.031 | 0.2 | 0.121 | Monophenol monooxygenase inhibitor | 0.121 0.061 CID_154699760 | CID_154699760 | |
| 0.077 | 0.247 | 0.455 | Platelet adhesion inhibitor | 0.455 0.007 CID_154699760 | CID_154699760 | |
| 0.067 | 0.243 | 0.177 | Diuretic | 0.177 0.056 CID_154699760 | CID_154699760 | |
| 0.014 | 0.201 | 0.043 | Carbonic anhydrase XIV inhibitor | 0.043 0.042 CID_154699760 | CID_154699760 | |
| 0.053 | 0.241 | 0.106 | Microtubule formation inhibitor | 0.106 0.08 CID_154699760 | CID_154699760 | |
| 0.13 | 0.325 | 0.394 | Apoptosis antagonist | 0.394 0.04 CID_154699760 | CID_154699760 | |
| 0.103 | 0.298 | 0.507 | Transcription factor NF kappa B inhibitor | 0.507 0.043 CID_154699760 | CID_154699760 | |
| 0.076 | 0.274 | 0.433 | Immunostimulant | 0.433 0.041 CID_154699760 | CID_154699760 | |
| 0.055 | 0.262 | 0.09 | Interleukin 12 antagonist | 0.09 0.073 CID_154699760 | CID_154699760 | |
| 0.031 | 0.255 | 0.164 | Expectorant | 0.164 0.03 CID_154699760 | CID_154699760 | |
| 0.035 | 0.282 | 0.101 | Alkylator | 0.101 0.087 CID_154699760 | CID_154699760 | |
| 0.06 | 0.323 | 0.173 | Spasmolytic | 0.173 0.142 CID_154699760 | CID_154699760 | |
| 0.033 | 0.301 | 0.146 | Uric acid excretion stimulant | 0.146 0.024 CID_154699760 | CID_154699760 | |
| 0.085 | 0.387 | 0.552 | Antithrombotic | 0.552 0.022 CID_154699760 | CID_154699760 | |
| 0.027 | 0.371 | 0.173 | AMP-activated protein kinase stimulant | 0.173 0.017 CID_154699760 | CID_154699760 | |
| 0.019 | 0.366 | 0.102 | Factor IXa inhibitor | 0.102 0.009 CID_154699760 | CID_154699760 | |
| 0.087 | 0.435 | 0.148 | CC chemokine 6 receptor antagonist | 0.148 0.024 CID_154699760 | CID_154699760 | |
| 0.049 | 0.411 | 0.323 | Vasodilator | 0.323 0.041 CID_154699760 | CID_154699760 | |
| 0.012 | 0.383 | 0.033 | Toll-Like receptor 4 agonist | 0.033 0.009 CID_154699760 | CID_154699760 | |
| 0.069 | 0.482 | 0.546 | Immunomodulator | 0.546 0.017 CID_154699760 | CID_154699760 | |
| 0.091 | 0.524 | 0.42 | Interleukin 2 agonist | 0.42 0.022 CID_154699760 | CID_154699760 | |
| 0.021 | 0.479 | 0.297 | Thrombolytic | 0.297 0.024 CID_154699760 | CID_154699760 | |
| 0.036 | 0.503 | 0.182 | Interleukin 4 antagonist | 0.182 0.029 CID_154699760 | CID_154699760 | |
| 0.007 | 0.603 | 0.056 | Neuraminidase (Influenza A) inhibitor | 0.056 0.016 CID_154699760 | CID_154699760 | |
| 0.022 | 0.623 | 0.156 | Toll-Like receptor 4 antagonist | 0.156 0.018 CID_154699760 | CID_154699760 | |
| 0.009 | 0.611 | 0.064 | Nitric oxide donor | 0.064 0.041 CID_154699760 | CID_154699760 | |
| 0.045 | 0.658 | 0.827 | Cyclophilin D inhibitor | 0.827 0.005 CID_154699760 | CID_154699760 | |
| 0.003 | 0.63 | 0.028 | 1,3-Beta-glucan synthase inhibitor | 0.028 0.02 CID_154699760 | CID_154699760 | |
| 0.016 | 0.658 | 0.099 | Thioredoxin inhibitor | 0.099 0.05 CID_154699760 | CID_154699760 | |
| 0.07 | 0.712 | 0.394 | Peptidyltransferase inhibitor | 0.394 0.007 CID_154699760 | CID_154699760 | |
| 0.014 | 0.661 | 0.428 | Platelet antagonist | 0.428 0.022 CID_154699760 | CID_154699760 | |
| 0.005 | 0.658 | 0.069 | Neuraminidase inhibitor | 0.069 0.034 CID_154699760 | CID_154699760 | |
| 0.017 | 0.676 | 0.063 | Adenine nucleotide translocase inhibitor | 0.063 0.024 CID_154699760 | CID_154699760 | |
| 0.033 | 0.695 | 0.222 | NOS3 expression enhancer | 0.222 0.033 CID_154699760 | CID_154699760 | |
| 0.022 | 0.702 | 0.502 | Antiobesity | 0.502 0.037 CID_154699760 | CID_154699760 | |
| 0.005 | 0.701 | 0.075 | Neuraminidase (influenza) inhibitor | 0.075 0.029 CID_154699760 | CID_154699760 | |
| 0.011 | 0.736 | 0.527 | Antioxidant | 0.527 0.017 CID_154699760 | CID_154699760 | |
| 0.003 | 0.738 | 0.139 | Antineoplastic antibiotic | 0.139 0.034 CID_154699760 | CID_154699760 | |
| 0.009 | 0.745 | 0.084 | Histone deacetylase SIRT1 stimulant | 0.084 0.04 CID_154699760 | CID_154699760 | |
| 0.009 | 0.745 | 0.084 | Histone deacetylase stimulant | 0.084 0.04 CID_154699760 | CID_154699760 | |
| 0.02 | 0.758 | 0.063 | Lipocortins synthesis agonist | 0.063 0.03 CID_154699760 | CID_154699760 | |
| 0.007 | 0.771 | 0.19 | Anticoagulant | 0.19 0.057 CID_154699760 | CID_154699760 | |
| 0.004 | 0.773 | 0.331 | Selectin antagonist | 0.331 0.004 CID_154699760 | CID_154699760 | |
| 0.005 | 0.784 | 0.149 | Topoisomerase I inhibitor | 0.149 0.042 CID_154699760 | CID_154699760 | |
| 0.01 | 0.79 | 0.314 | Tumour necrosis factor alpha release inhibitor | 0.314 0.048 CID_154699760 | CID_154699760 | |
| 0.009 | 0.817 | 0.096 | ATPase (Vacuolar H+) inhibitor | 0.096 0.045 CID_154699760 | CID_154699760 | |
| 0.005 | 0.825 | 0.159 | Hypolipemic | 0.159 0.128 CID_154699760 | CID_154699760 | |
| 0.007 | 0.834 | 0.075 | Antibiotic Aminoglycoside-like | 0.075 0.005 CID_154699760 | CID_154699760 | |
| 0.005 | 0.833 | 0.214 | Lipid peroxidase inhibitor | 0.214 0.036 CID_154699760 | CID_154699760 | |
| 0.008 | 0.842 | 0.073 | Glucose-6-phosphate translocase inhibitor | 0.073 0.014 CID_154699760 | CID_154699760 | |
| 0.017 | 0.874 | 0.382 | Hepatoprotectant | 0.382 0.015 CID_154699760 | CID_154699760 | |
| 0.012 | 0.876 | 0.408 | Immunosuppressant | 0.408 0.06 CID_154699760 | CID_154699760 | |
| 0.005 | 0.88 | 0.082 | Topoisomerase II alpha inhibitor | 0.082 0.052 CID_154699760 | CID_154699760 | |
| 0.021 | 0.902 | 0.195 | Caspase 3 stimulant | 0.195 0.177 CID_154699760 | CID_154699760 | |
| 0.005 | 0.888 | 0.099 | Protein 50S ribosomal subunit inhibitor | 0.099 0.013 CID_154699760 | CID_154699760 | |
| 0.005 | 0.891 | 0.309 | Nitric oxide antagonist | 0.309 0.039 CID_154699760 | CID_154699760 | |
| 0.009 | 0.907 | 0.58 | Hypoglycemic | 0.58 0.009 CID_154699760 | CID_154699760 | |
| 0.003 | 0.901 | 0.044 | Protein 30S ribosomal subunit inhibitor | 0.044 0.009 CID_154699760 | CID_154699760 | |
| 0.005 | 0.908 | 0.151 | Topoisomerase II inhibitor | 0.151 0.049 CID_154699760 | CID_154699760 | |
| 0.016 | 0.928 | 0.122 | Transcription factor NF kappa B stimulant | 0.122 0.024 CID_154699760 | CID_154699760 | |
| 0.007 | 0.92 | 0.608 | Angiogenesis stimulant | 0.608 0.006 CID_154699760 | CID_154699760 | |
| 0.007 | 0.937 | 0.13 | Interleukin 6 antagonist | 0.13 0.126 CID_154699760 | CID_154699760 | |
| 0.004 | 0.938 | 0.076 | Cell adhesion molecule inhibitor | 0.076 0.058 CID_154699760 | CID_154699760 | |
| 0.006 | 0.944 | 0.173 | Insulin secretagoues | 0.173 0.053 CID_154699760 | CID_154699760 | |
| 0.005 | 0.952 | 0.188 | Cell adhesion inhibitor | 0.188 0.028 CID_154699760 | CID_154699760 | |
| 0.005 | 0.966 | 0.425 | Apoptosis agonist | 0.425 0.102 CID_154699760 | CID_154699760 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |